Introduction
O steosarcoma (OS) or osteogenic sarcoma is an aggressive primary bone malignancy which is characterized by osteoid formation. [1] [2] [3] Bone malignancies are infrequent, consisting of a variety of tumors, the most common of which is OS. [1, 4, 5] OS typically affects the long bones, especially areas of growth such as the metaphysic; however, it rarely affects the jaws. [6] OS of the jaws, also known as gnathic OS, accounts for 6%-9% of all OSs and has an estimated incidence of 0.7 per million. [7, 8] Gnathic OS has a distinct biological behavior from that of long bones. [3] [4] [5] It tends to occur a decade or two later than its long bone counterpart which exhibits a bimodal distribution, occurring among patients in their second decade of life and the elderly. [5, 6] Patients present more often with a chief complaint of bony swelling rather than pain; it has a lower rate of metastasis and is said to have higher survival rates. [4] Reports of gnathic OS from sub-Saharan Africa are few and, to the best of our knowledge, there is none from North-West the mandibular lesions were located in the mandibular body/symphysis (8 [66.7%]), while others were situated in the mandibular angle/ramus region. All the maxillary lesions were situated in the premolar/molar region.
The most frequently encountered histological type was the osteoblastic OS (9 [52.9%]), while the telangiectatic type was the least frequently seen type (1 [5.9%]) [Figures 4 and 5] . High-grade tumors constituted 10 (58.8%), while low-grade tumors represented 7 (41.2%) cases. Twelve of the cases (70.6%) underwent surgical jaw resection with or without immediate reconstruction under general anesthesia, while the other patients were referred for neoadjuvant chemotherapy and/or concurrent chemo-radiotherapy [ Figure 6 ]. All but one of the patients referred for neoadjuvant chemotherapy died during the course of chemotherapy/chemoradiotherapy. The patients have been followed up for varying periods, during which recurrences were observed in three cases, nine patients remained clinically free of disease or were lost to follow-up and five mortalities were recorded.
Discussion
Gnathic OS was not commonly encountered in this study, representing 3.9% of all oral and maxillofacial lesion biopsies done over a period of 7 years. However, the prevalence observed is significantly higher than the report of Ogunlewe et al. who stated that osteogenic sarcomas of the jaws constituted 0.6% of all oral and maxillofacial biopsies done over a 10-year period. [9] The reason for this observation is unclear. Certain bone diseases such as Paget's disease, chronic osteomyelitis, and fibrous dysplasia have been associated with the development of OS, none of which was diagnosed in this series. [5, 10] It is estimated that <1% of OSs develop from the underlying Paget's disease of bone. [10] Previous irradiation has also been linked to the initiation of osteogenic sarcoma. [11] However, none of the patients had undergone any form of radiotherapy before presentation, thus ruling out cases of radiation-induced gnathic OSs. Radiotherapy-induced OS is said to account for about 5.5% of all OSs. [11] [12] [13] A slight male preponderance was noted in this study, which is comparable to some reports in the literature. [14] Conversely, it is at variance with the report of Lee et al. who found a slight female dominance. [4] Interestingly, Clark et al. reported a significant male preponderance, having 42 males and 24 females in their study. [15] The age characteristics of patients seen in this series are in keeping with several studies in the literature. [3, 16, 17] Wang et al. reported an age range and mean age of 9-80 years and 37.8 years, respectively. [7] Jaw swelling was one of the presenting complaints or the sole complaint among all the patients. Indeed, some of our patients Nigeria. This study aims to present our experience with gnathic OS at our center.
Materials and Methods
A review of the record of patients managed on account of histologically diagnosed gnathic osteogenic sarcoma at the Department of Dental and Maxillofacial Surgery, Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria, between March 2010 and March 2017, was done. Data retrieved included age, gender, socioeconomic status, symptoms/signs, site, and mode of treatment. Staging of the disease was done in accordance to the 2006 American Joint Committee on Cancer (AJCC) staging system. [5] Data were recorded and analyzed using IBM SPSS Statistics for Windows version 20 (IBM Corp., Armonk, NY, USA) and the results were presented with descriptive statistics.
Results
A total of 431 oral and maxillofacial lesions were biopsied during the study period, of which 17 (3.9%) cases were histologically diagnosed as OS. There were 9 (52.9%) males and 8 (47.1%) females, giving a male/female ratio of 1:0.9. The age ranged from 10 to 59 years with a mean (±standard deviation) of 31.4 (±16.1) years [ Table 1 ]. Majority of the patients presented with a chief complaint of jaw swelling (9 [52.9%]), while others had varying complaints at presentation [ Figures 1 and 2 ]. On examination, tooth mobility was invariably present in all cases, while mucosal ulceration was present in 3 (17.7%) cases.
The duration of symptoms before presentation ranged from 3 to 11 months with a mean (±SD) of 6.53 (±2.18) months [ Figure 3 ]. On palpation, regional lymph node enlargement was observed in 9 (52.9%) patients, although chest radiographs did not reveal the presence of any chest metastasis. Majority of the patients were in Stage IVb (9 [52.9%]), while others were in Stages IIb (4 [23.5%]) and IIa (4 [23.5%]). The mandible was the site of occurrence in 12 (70.6%) cases, while the maxilla was the site of occurrence in 5 (29.4%) cases. Majority of presented with large jaw tumors. This may be related to the often painless nature of gnathic OSs, making patients less likely to present at the hospital. [18] [19] [20] Padilla and Murrah opined that the tumors often begin as symptomless masses, which eventually become painful in the absence of intervention. [21] Tooth mobility was universally seen among all the patients in this series. This is expected because of the aggressive nature of the tumor and its penchant for causing widening of the periodontal membrane space. [5, 16, 22] Indeed, Garrington's sign (widening of the periodontal membrane space) is a common early sign of gnathic osteogenic sarcoma. [22] Similarly, abnormal tooth mobility may be the first sign of the disease. [23] This was not always the case in this series, considering that all the patients presented in Stage III or IV of the disease and pain was not a universal symptom. This is despite the fact that the mean duration of symptoms before presentation in this series is lower than that observed in their report. This may be related to the observation that majority of the patients in this study presented with high-grade tumors, which are expected to be more aggressive and thus infiltrate neural tissue causing pain earlier than their counterparts. [24] Mucosal ulcerations were noted in a number of cases. These ulcerations may be secondary to trauma from the opposing teeth which were found to often impinge on the mucosa overlying the tumors owing to the large sizes of these tumors.
Bleeding was also a common presenting complaint in this study. This may also be associated with the preponderance of high-grade lesions among the patients. [24] Late presentation was frequently observed among the patients. Several studies have stated varying reasons for late presentations among patients in our environment, ranging from the commonly practiced out-of-pocket payment system occasioned by financial incapacitation to psychosocial factors such as beliefs and culture. [25] [26] [27] Majority of the patients in this series were in the late stages of the disease at presentation, despite the seemingly short duration of the disease before presentation, which was <12 months in all cases. This is probably an attestation to the aggressiveness of this disease. Staging of OSs is often based on the Musculo-Skeletal Tumor Society, the AJCC, or Enneking staging systems rather than the well-known TNM staging system. [5, 28] This is because of the limited applicability of the TNM staging to OSs, owing to the rarity of metastasis to lymph nodes in these tumors. [28] The AJCC system of staging OSs has gained prominence over the years. [5, 29] The advanced disease stages seen among the cases in this study are largely due to the large tumor sizes and regional nodal involvement. Physical palpation was the mode of determination of nodal involvement in this study. Several modes of regional or distant node involvement have been described in the literature, including, physical palpation, ultrasonography (USS), computed tomography (CT) scan, and magnetic resonance imaging. [30] [31] [32] In a comparative study by Shetty et al., physical palpation, USS, and CT scan were said to have an accuracy of 72.43, 76.92, and 76.28, respectively. [30] Regional nodal involvement was seen in a significant number of patients. This is contrary to the widely acclaimed views that OS does not characteristically spread to the lymph nodes.
The mandible was the major site of occurrence in this study. This is in tandem with several reports in the literature. [9, 21] However, it is in contrast to the study by Clark et al. who reported a slight maxillary predominance. [15] Majority of the tumors affecting the mandible were seen in the mandibular body/symphysis. This is in consonance with the study by Ogunlewe et al., but contrasts with the report by Yildiz et al. who stated that most of the mandibular tumors were located around the 8 th molar, where active mandibular growth occurs. [9, 33] OS is said to have a predilection for areas of bone growth. [2, 3, 5] The modal site of occurrence of mandibular OS in this study is not unexpected, since mandibular growth centers are multiple. [34, 35] While the mandibular condylar cartilage is still widely believed to be the major mandibular growth center, the advent of the functional matrix theory has brought new perspectives. [34, 35] The osteoblastic variant of OS was the most commonly encountered subtype. This is in agreement with several reports in the literature. [21, 36] However, it in dissonance with the reports by Ogunlewe et al. and Bennett et al. who reported the chondroblastic type to be the most commonly seen in their series. [9, 37] The telangiectatic subtype was the least frequently diagnosed variant in this study. Controversies on the rarest subtypes exist, with the pendulum swinging between the fibroblastic and telangiectatic variants. [38] [39] [40] Majority of the lesions were high-grade tumors. This is in consonance with the report of Arslan et al., in which 89.6% of the cases reviewed were high-grade OSs. [41] However, their study consisted mainly of long bone lesions. Few studies state that the grade of gnathic OS exists in the literature; nonetheless, Padilla and Murrah in a review of seven cases of gnathic OSs stated that 85.7% of the cases were of low grade. [21] Multimodal treatment with varying treatment combination was often done in this series. In addition, adjuvant radiotherapy of 50 Gy was administered following surgery. Those who presented with unresectable tumors either had neoadjuvant chemotherapy to shrink the tumor or concurrent chemoradiotherapy alone. Although surgery aimed at obtaining tumor-free margins, remains the mainstay of treatment, especially when the patient presents early, and the tumor is accessible, multimodal treatment is gaining popularity. [42] Multimodal treatment is said to improve the disease-free rates from a paltry 10%-20% to as high as 60%. [42] Neoadjuvant chemotherapy was utilized in patients with large tumors which were deemed to be potentially amenable to surgery. Neoadjuvant chemotherapy is useful in achieving downstaging of tumors, making it especially useful in patients with large tumors that were encountered in this study. [43] [44] [45] Some authors have also alluded to the lessening effect of neoadjuvant chemotherapy on intraoperative blood loss. [43] The significant number of mortalities following chemotherapy may be because most of the patients sent for neoadjuvant chemotherapy were in advanced stages of the disease, thus the prognosis was poor, with or without the neoadjuvant chemotherapy. In addition, some of the deaths may be attributable to progressive disease, since majority of the patients presented late.
Due to the complex anatomy of the maxillofacial region and the presence of vital structures, especially in the maxillary region, obtaining free margins particularly in patients with large tumors is difficult. Utilization of intraoperative pathological adjuncts such as frozen section has been propounded by some researchers. [46] The mortality rate recorded in this study was 29.4%. OS of the jaws is reported to exhibit better survival rates than that of the long bones. [2] Several prognostic factors have been proposed for OSs, including the grade of tumor, stage at presentation, loss of heterozygosity of the retinoblastoma gene, and patients' age. [4, 28, 47] Some researchers have stated that the most consistent predictor of outcome is the extent of histologic necrosis subsequent to inductive chemotherapy. [4, 28, 47] 
Conclusion
Gnathic OSs continue to pose a challenge to oral and maxillofacial surgeons. Late presentation and its penchant for recurrence constitute a formidable cause of poor quality of life and mortality among the patients. Multimodal treatment is often beneficial in the treatment of the management of these cases; despite this, mortality is still high.
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